Funding Opportunities

• Biology of Lung, and Head and Neck Preneoplasias (R01)
  (PA-17-459)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Biology of Lung, and Head and Neck Preneoplasias (R21 - Clinical Trial Not Allowed)
  (PA-17-460)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Symptom Cluster Characterization in Chronic Conditions (R21)
  (PA-17-461)
  National Institute of Nursing Research
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Symptom Cluster Characterization in Chronic Conditions (R01)
  (PA-17-462)
  National Institute of Nursing Research
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NINDS CREATE Bio Optimization Track for Biologics (U01)
  (PAR-17-456)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): February 13, 2018; July 18, 2018; February 13, 2019; July 18, 2019; February 13, 2020; and July 20, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NINDS CREATE Bio Optimization Track for Biologics (U44)
  (PAR-17-457)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): February 13, 2018; July 18, 2018; February 13, 2019; July 18, 2019; February 13, 2020; and July 20, 2020 , February 12, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01)
  (PAR-17-458)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 28, 2018, September 26, 2018, March 28, 2019, September 26, 2019, March 26, 2020, September 28, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Biology of Lung, and Head and Neck Preneoplasias (R21)
  (PAR-17-460)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Limited Competition: A Data Resource for Analyzing Blood and Marrow Transplants (U24)
  (RFA-CA-17-031)
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 26, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late application will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24)
  (RFA-DK-17-034)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 3, 2017,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Clinical Coordinating Centers (U01)
  (RFA-DK-17-502)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): November 3, 2017,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Data Coordinating Center (U24)
  (RFA-DK-17-503)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 3, 2017,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Clinical Centers (U01)
  (RFA-DK-17-505)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 26, 2017 by 5:00 PM local time of applicant organization), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort Scientific and Data Coordinating Center (U24)
  (RFA-DK-17-506)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Limited Competition for the Continuation of the Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01)
  (RFA-DK-17-509)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (U24)
  (RFA-DK-17-510)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)
  (RFA-RM-17-015)
  NIH Roadmap Initiatives
  Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01)
  (RFA-RM-17-016)
  NIH Roadmap Initiatives
  Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)
  (RFA-RM-17-017)
  NIH Roadmap Initiatives
  Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01)
  (RFA-RM-17-018)
  NIH Roadmap Initiatives
  Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01)
  (RFA-RM-17-019)
  NIH Roadmap Initiatives
  Application Receipt Date(s): November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.